HOW DO WE MEASURE NEED, QUALITY, AND EFFICIENCY?

Clinical and economic data from real patient care are occupying an increasingly important area in the assessment of therapies because – unlike in clinical trials – no patient selection is involved and wide-ranging insights can be gained into therapies and the resulting costs.

More information on our patient care research projects is provided below.

Data collection from the primary system:

Systematic collection from all participating specialist physicians
Uniform data collection from the primary system

Representative data:

In the LiveTicker register: > 50 outpatient medical facilities with > 120 physicians throughout Germany
In the blood biobank: > 30 outpatient medical facilities with > 80 physicians throughout Germany
In the psycho-oncological register: > 50 outpatient and inpatient medical facilities with > 80 physicians throughout Germany

As of December 2020

Longitudinal data collection from all participating patients concerning all drug-based therapies:

In the LiveTicker register: since 2011
In the blood biobank: since 2016
In the psycho-oncological register: since 2015

Real-world evidence:

Consecutive collection of all relevant decision and treatment data from all consenting tumor patients at the time their therapy was planned
Enable longitudinal analysis of complete patient histories, including previous therapies, changes in dosage, and outcome data

Data pool monitored by a committee of oncological experts:

Continuous review of the input parameters and analysis options
Completeness, plausibility, and value of the dataset in daily clinical practice

Data validation:

Direct comparison with established registers and performance reports of the scientific medical societie

Non-interventional register study:

LiveTicker: Ethics committee vote, registration with the German Clinical Trials Register (DKRS) as well as with the WHO Clinical Trials Search Portal
Blood biobank: Ethics committee vote
Psycho-oncological register: Ethics committee vote, accreditation of the German Cancer Society (DKG), registration with the StudyBox of OnkoZert GmbH

Privacy by design:

Adherence to all current provisions of data protection law
Data processing only in the form of aggregated and thus anonymized data analysis

Retrospective analysis:

Retrospective monthly, quarterly, half-yearly, or annual analysis
Statistical subgroup analysis on request